AAN 2020: VMAT2 Inhibitors Prove Effective for Long-Term Treatment of Tardive Dyskinesia
Valbenazine and deutetrabenazine were evaluated.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Valbenazine and deutetrabenazine were evaluated.
Only registered members have full access to PracticeUpdate content.